Phreesia Review 2026: The Patient Intake Platform Powering 180 Million Visits

Overview: What Is Phreesia?

Phreesia is the dominant AI-powered patient intake platform in US healthcare, processing more than 180 million patient visits in 2026 and trading publicly on the NYSE as PHR. Founded in 2005, well before the current AI cycle, Phreesia has spent two decades building out a platform that handles digital check-in (via tablet, mobile, and kiosk), insurance verification, point-of-care payment collection, clinical screening tool administration (PHQ-9, GAD-7, social determinants), referral management, and revenue cycle optimization.

Phreesia's category is unsexy compared to ambient AI scribes or radiology AI, but it is operationally critical. Practice front desks are the highest-friction point in the patient experience and the largest source of administrative revenue leakage. Phreesia's value proposition is that automating intake captures more accurate insurance information, collects more co-pays at the point of care, and frees staff to handle clinical and patient relationship work rather than form re-entry.

Key Features

• AI-powered patient intake automation
• Digital check-in (tablet, mobile, kiosk)
• Automated insurance verification and eligibility
• Patient payment collection at point of care
• Clinical screening tools (PHQ-9, GAD-7, social determinants)
• Patient outreach and engagement campaigns
• Referral management
• Revenue cycle optimization

The AI Layer

Phreesia's AI is workflow AI rather than generative AI. It powers intelligent insurance verification that catches eligibility issues before the visit, predictive analytics for patient collections that surface which balances are most likely to be paid with a gentle nudge, automated patient outreach campaigns that target the right patients at the right time, and clinical screening administration that adapts to patient responses. There is no large language model component — Phreesia is not a generative AI company, and it doesn't pretend to be one. The advantage is that 20 years of intake data is hard to replicate with a generative model alone.

Pricing

Phreesia uses quote-based pricing that reportedly starts around $250/month and can reach $800+/month for practices using multiple add-on modules. There is no public price list. The pricing scales with practice size, modules selected, and patient visit volume.

Practical implication: Phreesia is rarely the cheapest intake option, and small practices may find that the price tag exceeds the operational savings. For mid-size and larger practices where staff time, payment capture, and accurate insurance information are bottlenecks, the ROI math is usually clear.

Pros & Cons

Who Should Use Phreesia?

Phreesia is best for mid-size to large physician practices and health systems where front-desk inefficiency is a real bottleneck, multi-location practices that need consistent intake across sites, specialty practices that need extensive clinical screening as part of intake, and organizations using Epic, Oracle Health, or athenahealth that want certified bi-directional intake integration. It is also a good fit for behavioral health and primary care practices that administer PHQ-9 and GAD-7 routinely.

It is not appropriate for very small solo practices where the cost outweighs the operational savings, or practices looking primarily for AI clinical documentation rather than administrative workflow. For ambient AI scribes, see Freed or Abridge.

Verdict

Phreesia is the safe, dominant choice in patient intake for mid-size and larger practices and health systems. It is not the most innovative AI platform and it is not the cheapest, but it is the most operationally reliable and the one most likely to integrate cleanly with whatever EHR and revenue cycle systems you already use. For practices where intake is a real friction point, Phreesia pays for itself. For practices where it is not, save the budget for clinical AI tools that move the needle on documentation burden.